Hypercalcemia

Parathyroid Hormone-Related Peptide Linked to Hematologic Malignancies

Published in Cancer Weekly, May 6th, 1996

Canadian clinicians report that parathyroid hormone-related peptide appears to be "... a pathogenetic factor in the development of hypercalcemia in hematologic malignancies, notably in non-Hodgkin's lymphoma," (Am J Med 1996;100:406-411).

The peptide mediates hypercalcemia, which contributes to the development of certain hematologic cancers. That's according to Dr. Richard Kremer and associates at McGill University in Montreal, Quebec, Canada. They compared parathyroid hormone-related peptide concentrations in 30 normal subjects and in 76 patients with either non-Hodgkin's lymphoma, Hodgkin's disease, multiple myeloma, or Waldenstrom's macroglobulinemia. Fourteen of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1996-05-06)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry